| abstract |
This document relates to materials and methods for treating a depression disorder (e.g., major depressive disorder, or a major depressive episode associated with bipolar disorder), and more particularly to materials and methods for treating major depressive disorder using agents that activate the aryl hydrocarbon receptor, without interacting with the glutamate receptor. Materials and methods for treating major depressive disorder by modulating the aryl hydrocarbon receptor system are provided herein. |